Obsidian Therapeutics, Inc. (OBX) stock
OBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$12.00−0.15 (-1.23%)
Close on Nov 20, 2026Market cap $741.28MP/E –Yield –
Obsidian Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Obsidian Therapeutics's total assets was $340.74M at Sep 30, 2026. For fiscal 2025 it was $88.58M.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $88.58M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $340.74M | – |
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q4 FY2025 | Dec 31, 2025 | $88.58M | – |
See a number that looks wrong?